- Bipolar disorder affects 5.7 million people in the US alone
- NRX-101 was previously granted fast track status
NeuroRx, announced on 11/13/18 that it has been granted... read more
NeuroRx, announced on 11/13/18 that it has been granted... read more
Prevencio, Inc. announced on 11/12/18 data demonstrating high accuracy for its multiple-protein HART AKITM test. Researchers believe these important findings, presented November 10 at the 2018... read more
Harpoon Therapeutics, Inc. announced on 11/11/18 the closing of a $70 million Series C equity financing. OrbiMed served as the lead new investor, along with new investors Cormorant, Ridgeback... read more
Israeli-based life sciences, healthcare, and technology venture capital firm aMoon is on pace to reach its hard cap of $750 million for its second fund. aMoon was Founded in 2016 by Yar Schindel,... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,